MyAverix Finance
F · Healthcare
ONWARD MEDICAL BV EO -12 (63E)
Biotechnology
ONWARD MEDICAL BV EO -12 (63E) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 63E
ONWARD MEDICAL BV EO -12 (63E) — FAQ
What is 63E's P/E ratio?
The price-to-earnings (P/E) ratio for ONWARD MEDICAL BV EO -12 (63E) is 25.00 (data as of 2026-05-23).
Does ONWARD MEDICAL BV EO -12 pay a dividend?
Dividend yield is not available in the current snapshot for ONWARD MEDICAL BV EO -12 (63E). Check the MyAverix Finance app for the latest dividend data.
What sector is ONWARD MEDICAL BV EO -12 in?
ONWARD MEDICAL BV EO -12 (63E) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 63E listed on?
63E is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.